Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.
APASL Single Topic Conference, İstanbul, Turkey, 27 - 29 September 2018, (Full Text)
- Publication Type: Conference Paper / Full Text
- City: İstanbul
- Country: Turkey
- Karadeniz Technical University Affiliated: Yes